MAP1LC3A and neoplasm: MAP1LC3A expression and CNVs were shown to correlate with multiple clinical and demographic parameters, whereas elevated MAP1LC3A expression was found to be associated with certain patient subgroups characterized by distinct clinical features, such as tumor stage, hemoglobin levels, and smoking history.